Different free prostate-specific antigen to total prostate-specific antigen ratios using three detecting systems

被引:6
|
作者
Huang, Hui-Qing [1 ,2 ]
Zhang, Yan [1 ]
Xu, Hua-Guo [1 ]
机构
[1] Nanjing Med Univ, Dept Lab Med, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China
[2] Oriental & Foreign Related Hosp, Dept Lab Med, Lianyungang, Peoples R China
基金
中国国家自然科学基金;
关键词
immunoenzymatic assay; prostate-specific antigen; reversed ratio;
D O I
10.1002/jcla.22231
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
BackgroundProstate-specific antigen (PSA) is used as an indicative marker of a pathologic condition of the prostate, and the ratio of free PSA (fPSA) to total PSA (tPSA) helps to distinguish benign prostatic hyperplasia (BPH) from prostate cancer (PCa). In this study, we present some reversed ratios of fPSA to tPSA and analyze the possible mechanism. MethodsUsing the UniCel DxI800 Access Immunoassay System, eight reversed fPSA to tPSA ratios were obtained, and then these samples were retested with an Abbott Architect i2000 Immunoassay Analyser and Cobas e602. ResultsFour of the eight reversed ratios kept a ratio >1 using Abbott Architect i2000, and seven of them turned into a ratio <1 using Cobas e602. ConclusionIn consideration of the assay these three detecting systems apply, the possible reason of the reversed ratios can be heterophile antibodies. To get accurate reason, further study is required.
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Classifying prostate cancer patients based on total prostate-specific antigen and free prostate-specific antigen features by support vector machine
    Nguyen Thi Hong Nhung
    Vu Tran Minh Khuong
    Vu Quang Huy
    Pham The Bao
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (02) : 818 - 825
  • [42] Isoforms of free prostate-specific antigen
    Haese, A
    Noldus, J
    Steuber, T
    Huland, H
    Lilja, H
    UROLOGE A, 2004, 43 (06): : 675 - 679
  • [43] Clinical implications of free-to-total immunoreactive prostate-specific antigen ratios
    Wymenga, LFA
    Duisterwinkel, FJ
    Groenier, K
    Visser-van Brummen, P
    Marrink, J
    Mensink, HJA
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2000, 34 (03): : 181 - 187
  • [44] The measurement of complexed prostate-specific antigen has a better performance than total prostate-specific antigen
    Herrmann, W
    Stöckle, M
    Sand-Hill, M
    Hübner, U
    Herrmann, M
    Obeid, R
    Wullich, B
    Loch, T
    Geisel, J
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2004, 42 (09) : 1051 - 1057
  • [45] Short-term stability of the molecular forms of prostate-specific antigen and effect on percent complexed prostate-specific antigen and percent free prostate-specific antigen
    Sokoll, LJ
    Bruzek, DJ
    Dua, R
    Dunn, W
    Mohr, P
    Wallerson, G
    Eisenberger, M
    Partin, AW
    Chan, DW
    UROLOGY, 2002, 60 (4A) : 24 - 30
  • [46] MEASUREMENT OF SERUM PROSTATE-SPECIFIC ANTIGEN USING IMX PROSTATE-SPECIFIC ANTIGEN-ASSAY
    KLEE, GG
    DODGE, LA
    ZINCKE, H
    OESTERLING, JE
    JOURNAL OF UROLOGY, 1994, 151 (01): : 94 - 98
  • [47] The impact of intraoperative manipulation of the prostate on total and free prostate-specific antigen
    Oberpenning, F
    Schmid, HP
    Fuchs-Surdel, W
    Hertle, L
    Semjonow, A
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2002, 17 (03): : 154 - 160
  • [48] The additional value of free prostate specific antigen to the battery of age-dependent prostate-specific antigen, prostate-specific antigen density and velocity
    Barak, M
    Cohen, M
    Mecz, Y
    Stein, A
    Rashkovitzki, R
    Laver, B
    Lurie, A
    EUROPEAN JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1997, 35 (06): : 475 - 481
  • [49] Molecular forms of serum prostate-specific antigen - The clinical value of percent free prostate-specific antigen
    Abrahamsson, PA
    Lilja, H
    Oesterling, JE
    UROLOGIC CLINICS OF NORTH AMERICA, 1997, 24 (02) : 353 - +
  • [50] A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy
    Auprich, Marco
    Augustin, Herbert
    Budaeus, Lars
    Kluth, Luis
    Mannweiler, Sebastian
    Shariat, Shahrokh F.
    Fisch, Margit
    Graefen, Markus
    Pummer, Karl
    Chun, Felix K. -H.
    BJU INTERNATIONAL, 2012, 109 (11) : 1627 - 1635